Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy

Detalles Bibliográficos
Autores principales: Raje, Noopur, Mateos, María-Victoria, Iida, Shinsuke, Reece, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322818/
https://www.ncbi.nlm.nih.gov/pubmed/37407575
http://dx.doi.org/10.1038/s41408-023-00866-y
_version_ 1785068840427716608
author Raje, Noopur
Mateos, María-Victoria
Iida, Shinsuke
Reece, Donna
author_facet Raje, Noopur
Mateos, María-Victoria
Iida, Shinsuke
Reece, Donna
author_sort Raje, Noopur
collection PubMed
description
format Online
Article
Text
id pubmed-10322818
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103228182023-07-07 Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy Raje, Noopur Mateos, María-Victoria Iida, Shinsuke Reece, Donna Blood Cancer J Correction Nature Publishing Group UK 2023-07-06 /pmc/articles/PMC10322818/ /pubmed/37407575 http://dx.doi.org/10.1038/s41408-023-00866-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Raje, Noopur
Mateos, María-Victoria
Iida, Shinsuke
Reece, Donna
Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
title Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
title_full Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
title_fullStr Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
title_full_unstemmed Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
title_short Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
title_sort correction: clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322818/
https://www.ncbi.nlm.nih.gov/pubmed/37407575
http://dx.doi.org/10.1038/s41408-023-00866-y
work_keys_str_mv AT rajenoopur correctionclinicalevidenceforimmunebasedstrategiesinearlylinemultiplemyelomacurrentchallengesindecisionmakingforsubsequenttherapy
AT mateosmariavictoria correctionclinicalevidenceforimmunebasedstrategiesinearlylinemultiplemyelomacurrentchallengesindecisionmakingforsubsequenttherapy
AT iidashinsuke correctionclinicalevidenceforimmunebasedstrategiesinearlylinemultiplemyelomacurrentchallengesindecisionmakingforsubsequenttherapy
AT reecedonna correctionclinicalevidenceforimmunebasedstrategiesinearlylinemultiplemyelomacurrentchallengesindecisionmakingforsubsequenttherapy

Ejemplares similares